FIELD: medicine.
SUBSTANCE: method involves screening for ferritin in venous blood by its magnitude below 35 ng/ml prescribed oral iron supplements in conventional prophylactic doses for a period of 3 months, and if three months ferritin content in the venous blood again below 35 ng/ml receive iron-containing preparations continued for a further 3 months.
EFFECT: use of the invention allows to reduce the frequency and severity of iron deficiency anemia in pregnant women, minors, prevent degenerative processes in the placenta, placental insufficiency and fetal growth retardation.
2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING IRON DEFICIENCY ANEMIA IN PREGNANT WOMEN OF DIFFERENT SOMATOTYPES | 2019 |
|
RU2723359C1 |
| METHOD FOR TREATING ANEMIA DURING PREGNANCY | 2006 |
|
RU2319489C2 |
| METHOD OF TREATING ANAEMIA IN PREGNANT WOMEN | 2010 |
|
RU2445966C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN WITH IRON-DEFICIENCY ANEMIA | 2009 |
|
RU2418589C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ANEMIA SYNDROME IN PREGNANT WOMEN WITH CARBOHYDRATE METABOLISM DISORDER | 2018 |
|
RU2673538C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF ANEMIA IN PREGNANT WOMEN | 2009 |
|
RU2407011C1 |
| METHOD FOR PREVENTION OF FETOPLACENTAL INSUFFICIENCY IN GESTATIONAL AUTOHEMODILUTION | 2008 |
|
RU2375087C1 |
| METHOD FOR TREATMENT OF ASIDEROTIC ANEMIA | 2004 |
|
RU2272641C2 |
| METHOD OF TREATING ANAEMIA IN PREGNANT WOMEN | 2013 |
|
RU2532387C1 |
| METHOD FOR PREDICTING ANEMIA IN PREGNANT WOMEN WITH COVID-19 PNEUMONIA | 2022 |
|
RU2772906C1 |
